Head And Neck Cancers Lip

1

Review clinical trials related to Head And Neck Cancers Lip. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

This is a multicenter, open-label, Phase 1/2 study of orally administered VMD-928 monotherapy and in combination with pembrolizumab in adult subjects with advanced solid tumors or lymphoma that have progressed or are non responsive to available therapies and for which no standard or available curative therapy exists

Participants needed: 242
Trial details
Phase: Phase 1, Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: VM Oncology, LLCUpdated: Dec 11, 2025Locations: 15
Eligibility criteria

Head and Neck Cancers ("HNC") (of any types), [+17]

Received chemotherapy having delayed toxicity within the last 14 days (six weeks... [+23]